Agonist Discovery for Membrane Proteins on Live Cells by Using DNA-encoded Libraries.
Yiran HuangRui HouFong Sang LamYunxuan JiaYu ZhouXun HeGang LiFeng XiongYan CaoDongyao WangXiaoyu LiPublished in: Journal of the American Chemical Society (2024)
Identifying biologically active ligands for membrane proteins is an important task in chemical biology. We report an approach to directly identify small molecule agonists against membrane proteins by selecting DNA-encoded libraries (DELs) on live cells. This method connects extracellular ligand binding with intracellular biochemical transformation, thereby biasing the selection toward agonist identification. We have demonstrated the methodology with three membrane proteins: epidermal growth factor receptor (EGFR), thrombopoietin receptor (TPOR), and insulin receptor (INSR). A ∼30 million and a 1.033 billion-compound DEL were selected against these targets, and novel agonists with subnanomolar affinity and low micromolar cellular activities have been discovered. The INSR agonists activated the receptor by possibly binding to an allosteric site, exhibited clear synergistic effects with insulin, and activated the downstream signaling pathways. Notably, the agonists did not activate the insulin-like growth factor 1 receptor (IGF-1R), a highly homologous receptor whose activation may lead to tumor progression. Collectively, this work has developed an approach toward "functional" DEL selections on the cell surface and may provide a widely applicable method for agonist discovery for membrane proteins.
Keyphrases
- small molecule
- epidermal growth factor receptor
- induced apoptosis
- type diabetes
- binding protein
- tyrosine kinase
- small cell lung cancer
- signaling pathway
- cell surface
- cell cycle arrest
- circulating tumor
- epithelial mesenchymal transition
- single molecule
- dna damage
- cell free
- poor prognosis
- glycemic control
- adipose tissue
- long non coding rna
- metabolic syndrome
- cell death
- cell proliferation
- reactive oxygen species
- nucleic acid